Vicarious Surgical Inc. has announced the successful completion of an in-vivo porcine lab conducted in December 2025, marking significant progress in the development of its robotic surgical system. This was the company’s first in-vivo animal lab in several years and the first to use an integrated system architecture rather than early-stage prototypes. Surgeons completed key elements of a ventral hernia repair and assessed various system capabilities, including instrument articulation and visualization. The lab, conducted for research and development purposes only, generated data that will inform ongoing design refinement and optimization efforts. The results have been announced and are being incorporated into the company’s development plans.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vicarious Surgical Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260105183855) on January 12, 2026, and is solely responsible for the information contained therein.